Connection

MATTHEW MCMILLIN to Azoxymethane

This is a "connection" page, showing publications MATTHEW MCMILLIN has written about Azoxymethane.
Connection Strength

1.183
  1. Characterization of hepatic pathology during azoxymethane-induced acute liver failure. World J Gastroenterol. 2025 Mar 28; 31(12):103952.
    View in: PubMed
    Score: 0.237
  2. CD47 signaling induces hepatic cell death and microglia activation during hepatic encephalopathy. Metab Brain Dis. 2024 Dec 10; 40(1):57.
    View in: PubMed
    Score: 0.233
  3. Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor ?1. Am J Pathol. 2020 02; 190(2):347-357.
    View in: PubMed
    Score: 0.164
  4. Elevated circulating TGF?1 during acute liver failure activates TGF?R2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice. J Neuroinflammation. 2019 Apr 02; 16(1):69.
    View in: PubMed
    Score: 0.157
  5. Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice. Gene Expr. 2018 08 22; 18(3):171-185.
    View in: PubMed
    Score: 0.148
  6. Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. J Neuroinflammation. 2016 08 26; 13(1):198.
    View in: PubMed
    Score: 0.131
  7. Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. J Neuroinflammation. 2014 Jul 10; 11:121.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.